MANILA, Philippines — The Philippine Hospital Association (PHA) on Friday said it is “unfair” to accuse hospitals of overpricing the antiviral drug remdesivir used in the treatment of COVID-19 patients, saying hospitals are only selling the drug based on the price set by distributors.
PHA president Dr. Jaime Almora said some hospitals are selling the drug at P25,000 because of its expensive price from the distributors, even as the Department of Health (DOH) said the drug should be sold cheaper.
“Naglabas ang DOH ng presyo ng remdesivir na P5,000. ‘Yung mga hospitals naman, especially sa private hospitals, ang binibili nila P25,000 o kaya a little bit less, let’s say…
Keep on reading: ‘Unfair’ to accuse hospitals of overpricing remdesivir — PHA